The Society for Women’s Health Research (SWHR ®) supports the National Institute of Health’s (NIH) move to include sex as a biological variable in future research. Since 1990, SWHR has been working to increase equality in healthcare research, knowing that there are biological sex differences between women and men, and that these differences matter.
The Society for Women’s Health Research (SWHR®) held its second interdisciplinary roundtable on understanding sex and gender differences in Alzheimer’s disease May 28-29, 2015 at the Hyatt Regency Crystal City in Arlington, Va.
The Food and Drug Administration (FDA) Advisory Committee has made history for women by recommending approval of Sprout Pharmaceuticals’ twice-rejected female libido drug Flibanserin.
SWHR announces “Beyond the Bruises,” an online campaign uniting survivors, advocates, organizations, and celebrities in bringing awareness to the effects of domestic violence on chronic disease.
The Society for Women’s Health Research (SWHR) has teamed with HealthyWomen, the National Association of Nurse Practitioners in Women’s Health, and the Coalition of Labor Union Women in partnership with CardioDx on a new patient advocacy campaign, Spread the Word, to empower women to be proactive in discussing their heart health and testing options with their healthcare providers.